Skip to main content
. 2013 Feb 7;13:75. doi: 10.1186/1471-2334-13-75

Figure 3.

Figure 3

Cost-effectiveness (Euro/QALY and Euro/LY) for the bivalent and quadrivalent HPV vaccine. Black: Euros per life year gained; red: Euros per quality-adjusted life years gained; circles: quadrivalent vaccine; squares: bivalent vaccine.